The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Effectiveness and safety of radium-223 in men with metastatic castration-resistant prostate cancer (mCRPC): A systematic literature review of 48 real-world studies.
 
Michaela Lunan
Consulting or Advisory Role - RTI Health Solutions (Inst)
Research Funding - RTI Health Solutions (Inst)
 
Amit Raval
Employment - Bayer
Stock and Other Ownership Interests - Bayer
 
Nguyen Thi Nhan Phan
Consulting or Advisory Role - RTI Health Solutions (Inst)
Research Funding - RTI Health Solutions (Inst)
 
Matthew Korn
Employment - Bayer HealthCare Pharmacuticals
Stock and Other Ownership Interests - Bayer HealthCare Pharmacuticals; daiichi sankyo; POINT Biopharma
Travel, Accommodations, Expenses - Bayer HealthCare Pharmacuticals
 
Vanessa Quintero
Employment - Bayer
 
Rana McKay
Consulting or Advisory Role - Ambrx; Ambrx; Arcus Biosciences; Astellas Medivation; AstraZeneca; AVEO; Bayer; Blue Earth Diagnostics; Bristol-Myers Squibb; Calithera Biosciences; Caris Life Sciences; Dendreon; Esiai; Exelixis; Janssen; Lilly; Merck; Myovant Sciences; NeoMorph; Novartis; Pfizer; Sanofi; Seagen; Sorrento Therapeutics; Sumitomo Pharma Oncology; Telix Pharmaceuticals; Tempus; Vividion Therapeutics
Research Funding - Artera (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol Myers Squibb (Inst); Exelixis (Inst); Oncternal Therapeutics (Inst); Tempus (Inst)